Antineoplastic Agents

Author(s):  
Philip N. Patsalos
2018 ◽  
Author(s):  
Roberto Collado-Borrell ◽  
Vicente Escudero-Vilaplana ◽  
Almudena Ribed ◽  
Helena Anglada-Mart�nez ◽  
Maite Mart�n-Conde ◽  
...  

2002 ◽  
Vol 65 (12) ◽  
pp. 1886-1891 ◽  
Author(s):  
George R. Pettit ◽  
Atsushi Numata ◽  
Chika Iwamoto ◽  
Hideaki Morito ◽  
Takeshi Yamada ◽  
...  

Nanoscale ◽  
2021 ◽  
Author(s):  
Zhanlin Zhang ◽  
Dandan Zhang ◽  
Bo Qiu ◽  
Wenxiong Cao ◽  
Yuan Liu ◽  
...  

Cancer chemotherapy remains challenging to pass through various biological and pathological barriers from blood circulation, tumor infiltration and cellular uptake before intracellular release of antineoplastic agents. Herein, icebreaker-inspired Janus nanomotors...


Tetrahedron ◽  
1985 ◽  
Vol 41 (6) ◽  
pp. 985-994 ◽  
Author(s):  
G.R Pettit ◽  
Y Kamano ◽  
R Aoyagi ◽  
C.L Herald ◽  
D.L Doubek ◽  
...  

1977 ◽  
Vol 44 (4) ◽  
pp. 527-534 ◽  
Author(s):  
William K. Bottomley ◽  
Elliott Perlin ◽  
George R. Ross

1984 ◽  
Vol 92 (3) ◽  
pp. 365-368 ◽  
Author(s):  
William J. Richtsmeier

The interferons (IFNs) are a group of proteins produced by cells of all vertebrate animals in response to a variety of stimuli. The ability to stimulate antiviral resistance, which was the first observed property of the IFNs, is still of great interest and remains the basic criterion by which the interferons are measured 1 (even into the most recent era of radioimmunoassay systems). It is the recent clinical uses of these substances as antineoplastic agents that has brought them to the attention of clinicians and the public in general. The IFN molecules exert their effects, much as hormones do, by attaching to specific receptors on other cells of the same species. Once attached, the IFNs induce cells to undergo a series of biochemical changes that renders them resistant to further virus propagation. To be an IFN, a substance must be a protein devoid of accompanying nucleic acid or endotoxin (both of which are interferon inducers). Treated cells must undergo de novo RNA and protein synthetic activity to acquire antiviral resistance.


ChemInform ◽  
2010 ◽  
Vol 22 (8) ◽  
pp. no-no
Author(s):  
G. R. PETTIT ◽  
C. L. HERALD ◽  
J. E. LEET ◽  
R. GUPTA ◽  
D. E. SCHAUFELBERGER ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document